Age-related macular degeneration and its associated factors, in Khartoum locality, Sudan

Saleh Mohammad Sulaiman Harun, Mounkaila Noma, Zeinab Yahia El Roubi



Age-Related Macular Degeneration (AMD or ARMD), also known as Macular Degeneration, is an eye disorder that slowly destroys sharp, central vision. The causal factors of ARMD remain a controversy. The proposed study aimed to participate in controversy in focusing on the magnitude of ARMD in tertiary hospital in Khartoum state.  


A hospital-based retrospective cross sectional study design was implemented in Makkah Eye Complex. Data on ARMD was derived from an electronic data based made available to the researcher. The data in excel format was uploaded in the SPSS version 21. All the 79 cases of ARMD was retained and summarized through descriptive statistics to produce graphics and frequency tables to address the research objectives and chi square test was performed to assess the association between ARMD and gender and age. A decision role was set prior to the test to reject the null hypothesis that there was no association whenever the p value is < 0.05.


During the period covered by the study a total of 86,788 patients attended Makkah Eye Complex, 79 patients among those was diagnosed as Age Related Macular Degeneration disease. This represents a prevalence of Age Related Macular Degeneration (ARMD) of 0.09 % (79/86,788).


Regarding age, our findings confirmed that the condition is related to aging. It occurred earlier in our research contrary to the commonly reported years of occurrence. However, the limited data available to us indicates the need to establish an electronic patient registry to enable to describe patients sociodemographic characteristics, the disease risk factors and patient management and related outcomes.


Public Health, Ophthalmology, Eye diseases, Age Related Macular Degeneration

Full Text:



M F Land and, Fernald RD. The Evolution of Eyes [Internet]. 2003 [cited 2017 Feb 12]. Available from:

Macular degeneration - age-related [Internet]. [cited 2017 Feb 12]. Available from:

Ethiopia KP BPharmS (Hons), MRPharmS, RPh, CPhFreelance Medical WriterOrlando, FloridaConsultant PharmacistNordic Medical CentreAddis Ababa. Age-Related Macular Degeneration 2015 [Internet]. [cited 2017 Feb 12]. Available from:

Facts About Age-Related Macular Degeneration | National Eye Institute [Internet]. [cited 2017 Feb 12]. Available from:

Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004 Nov;82(11):844–51.

Arnold C, Winter L, Fröhlich K, Jentsch S, Dawczynski J, Jahreis G, et al. Macular Xanthophylls and ω-3 Long-Chain Polyunsaturated Fatty Acids in Age-Related Macular Degeneration: A Randomized Trial. JAMA Ophthalmol. 2013 May 1;131(5):564–72.

Blindness and Vision Impairment | Gateway to Health Communication | CDC [Internet]. [cited 2017 Feb 11]. Available from:

QRG-6.pdf [Internet]. [cited 2017 Feb 17]. Available from:

Gupta SK, Murthy GVS, Morrison N, Price GM, Dherani M, John N, et al. Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1007–11.

Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106-116.

Klein R, Klein BEK. The Prevalence of Age-Related Eye Diseases and Visual Impairment in Aging: Current Estimates. Invest Ophthalmol Vis Sci. 2013 Dec;54(14):ORSF5-ORSF13.

Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012 May;96(5):752–6.

Akuffo KO, Nolan J, Stack J, Moran R, Feeney J, Kenny RA, et al. Prevalence of age-related macular degeneration in the Republic of Ireland. Br J Ophthalmol. 2015 Aug;99(8):1037–44.

Nowak MS, Smigielski J. The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland. J Ophthalmol. 2015 Feb 19;2015:e605814.

Huang EJ-C, Wu S-H, Lai C-H, Kuo C-N, Wu P-L, Chen C-L, et al. Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study. Eye Lond Engl. 2014 Jun;28(6):705–14.

Moon BG, Joe SG, Hwang J, Kim HK, Choe J, Yoon YH. Prevalence and Risk Factors of Early-Stage Age-Related Macular Degeneration in Patients Examined at a Health Promotion Center in Korea. J Korean Med Sci. 2012 May 1;27(5):537–41.

Kulkarni SR, Aghashe SR, Khandekar RB, Deshpande MD. Prevalence and determinants of age-related macular degeneration in the 50 years and older population: a hospital based study in Maharashtra, India. Indian J Ophthalmol. 2013 May;61(5):196–201.

Rasoulinejad SA, Zarghami A, Hosseini SR, Rajaee N, Rasoulinejad SE, Mikaniki E. Prevalence of age-related macular degeneration among the elderly. Casp J Intern Med. 2015;6(3):141–7.

Mathenge W, Bastawrous A, Peto T, Leung I, Foster A, Kuper H. Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. PLoS Med. 2013;10(2):e1001393.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Open Science Journal (OSJ) is multidisciplinary Open Access journal. We accept scientifically rigorous research, regardless of novelty. OSJ broad scope provides a platform to publish original research in all areas of sciences, including interdisciplinary and replication studies as well as negative results.